HMGB-1 is released from the damaged cells and expressed by the activated platelets, leading to immune system activation via RAGE, TLR2, and TLR4. HMGB-1-mediated PMN activation subsequently contributes to microvascular thrombosis and NETosis (67, 68). Here, HMGB1 is linked to Venous thrombosis.